BALB/c mice, but not C57BL/6 mice immunized with a ΔclpB mutant of Francisella tularensis subspecies tularensis are protected against respiratory challenge with wild-type bacteria: association of protection with post-vaccination and post-challenge immune responses.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Vaccine

• Publication date

  2012-05-21

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.vaccine.2012.03.036PMID 22484348
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tularemia vaccines: recent developments and remaining hurdles.

  2011cited by this paper
• Persistence of cell‐mediated immunity three decades after vaccination with the live vaccine strain of Francisella tularensis

  2011cited by this paper
• Immunoproteomic analysis of the human antibody response to natural tularemia infection with Type A or Type B strains or LVS vaccination.

  2011cited by this paper
• A Francisella tularensis Live Vaccine Strain (LVS) Mutant with a Deletion in capB, Encoding a Putative Capsular Biosynthesis Protein, Is Significantly More Attenuated than LVS yet Induces Potent Protective Immunity in Mice against F. tularensis Challenge

  2010cited by this paper
• Molecular Immune Responses to Aerosol Challenge with Francisella tularensis in Mice Inoculated with Live Vaccine Candidates of Varying Efficacy

  2010cited by this paper
• Predictive models and correlates of protection for testing biodefence vaccines

  2010cited by this paper
• Differential ability of novel attenuated targeted deletion mutants of Francisella tularensis subspecies tularensis strain SCHU S4 to protect mice against aerosol challenge with virulent bacteria: effects of host background and route of immunization.

  2010cited by this paper
• Long lived protection against pneumonic tularemia is correlated with cellular immunity in peripheral, not pulmonary, organs.

  2010cited by this paper
• Immunoproteomics Analysis of the Murine Antibody Response to Vaccination with an Improved Francisella tularensis Live Vaccine Strain (LVS)

  2010cited by this paper
• Epitope-based vaccination against pneumonic tularemia.

  2009cited by this paper
• Generation of heterogeneous memory T cells by live attenuated tularemia vaccine in humans.

  2009cited by this paper
• Working toward the Future: Insights into Francisella tularensis Pathogenesis and Vaccine Development

  2009cited by this paper
• Rationally designed tularemia vaccines

  2009cited by this paper
• Characterization of rationally attenuated Francisella tularensis vaccine strains that harbor deletions in the guaA and guaB genes.

  2009cited by this paper
• Safety, reactogenicity and immunogenicity of Francisella tularensis live vaccine strain in humans.

  2009cited by this paper
• An improved Francisella tularensis live vaccine strain (LVS) is well tolerated and highly immunogenic when administered to rabbits in escalating doses using various immunization routes.

  2008cited by this paper
• Proteomic analysis of antibody response in a case of laboratory-acquired infection withFrancisella tularensis subsp.tularensis

  2008cited by this paper
• Native Outer Membrane Proteins Protect Mice against Pulmonary Challenge with Virulent Type A Francisella tularensis

  2008cited by this paper
• Innate and Adaptive Immunity to Francisella

  2007cited by this paper
• Transcriptome analysis of human immune responses following live vaccine strain (LVS) Francisella tularensis vaccination.

  2007cited by this paper
• Immunodominant Francisella tularensis antigens identified using proteome microarray. ©Crown Copyright 2007 Dstl

  2007cited by this paper
• Identification of immunoreactive antigens in membrane proteins enriched fraction from Francisella tularensis LVS.

  2007cited by this paper
• Active Suppression of the Pulmonary Immune Response by Francisella tularensis Schu41

  2007cited by this paper
• From protein microarrays to diagnostic antigen discovery: a study of the pathogen Francisella tularensis

  2007cited by this paper
• Tularemia: History, Epidemiology, Pathogen Physiology, and Clinical Manifestations

  2007cited by this paper
• Immunoproteomic analysis of the murine antibody response to successful and failed immunization with live anti-Francisella vaccines.

  2006cited by this paper
• Dominance of human innate immune responses in primary Francisella tularensis live vaccine strain vaccination.

  2006cited by this paper
• Intranasal Vaccination Induces Protective Immunity against Intranasal Infection with Virulent Francisella tularensis Biovar A

  2005cited by this paper
• Francisella tularensis proteome: low levels of ASB-14 facilitate the visualization of membrane proteins in total protein extracts.

  2005cited by this paper
• Aerosol-, but not intradermal-immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an alphabeta T cell- and interferon gamma- dependent mechanism.

  2005cited by this paper
• Proteomic analysis of anti‐Francisella tularensis LVS antibody response in murine model of tularemia

  2005cited by this paper
• Preventive vaccines against bioterrorism: evaluation of efficacy and safety.

  2004cited by this paper
• Susceptibility of various mouse strains to systemically- or aerosol-initiated tularemia by virulent type A Francisella tularensis before and after immunization with the attenuated live vaccine strain of the pathogen.

  2004cited by this paper
• Multiple T Cell Subsets Control Francisella tularensis LVS Intracellular Growth Without Stimulation Through Macrophage Interferon γ Receptors

  2003cited by this paper
• Tularemia in BALB/c and C57BL/6 mice vaccinated with Francisella tularensis LVS and challenged intradermally, or by aerosol with virulent isolates of the pathogen: protection varies depending on pathogen virulence, route of exposure, and host genetic background.

  2003cited by this paper
• Mapping of immunoreactive antigens of Francisella tularensis live vaccine strain

  2002cited by this paper
• Tularemia as a biological weapon: medical and public health management.

  2001cited by this paper
• Various membrane proteins of Francisella tularensis induce interferon-gamma production in both CD4+ and CD8+ T cells of primed humans.

  1992cited by this paper
• Aerogenic immunization of man with live Tularemia vaccine.

  1966cited by this paper
• Prophylactic effectiveness of live and killed tularemia vaccines. I. Production of vaccine and evaluation in the white mouse and guinea pig.

  1961cited by this paper
• AEROSOL INFECTION OF MAN WITH PASTEURELLA TULARENSIS.

  1961cited by this paper
• Tularemia vaccine study. II. Respiratory challenge.

  1961cited by this paper
• STUDIES WITH TULAREMIA VACCINES IN VOLUNTEERS: III. SEROLOGIC ASPECTS FOLLOWING INTRACUTANEOUS OR RESPIRATORY CHALLENGE IN BOTH VACCINATED AND NONVACCINATED VOLUNTEERS

  1961cited by this paper

• Animal modelling with the Francisella tularensis subspecies holarctica strain OR96-0246

  2025cites this paper
• Marmosets as models of infectious diseases

  2024cites this paper
• Analyses of human immune responses to Francisella tularensis identify correlates of protection

  2023cites this paper
• In vivo and in vitro immune responses against Francisella tularensis vaccines are comparable among Fischer 344 rat substrains

  2023cites this paper
• Development of New Live Tularemia Vaccines: Problems and Prospects

  2022cites this paper
• Working correlates of protection predict SchuS4-derived-vaccine candidates with improved efficacy against an intracellular bacterium, Francisella tularensis

  2022cites this paper
• Shotgun Immunoproteomic Approach for the Discovery of Linear B-Cell Epitopes in Biothreat Agents Francisella tularensis and Burkholderia pseudomallei

  2021cites this paper
• A study of innate immune kinetics reveals a role for a chloride transporter in a virulent Francisella tularensis type B strain

  2021cites this paper
• The O-Ag Antibody Response to Francisella Is Distinct in Rodents and Higher Animals and Can Serve as a Correlate of Protection

  2021cites this paper
• Modern Development and Production of a New Live Attenuated Bacterial Vaccine, SCHU S4 ΔclpB, to Prevent Tularemia

  2021cites this paper
• Novel Transcriptional and Translational Biomarkers of Tularemia Vaccine Efficacy in a Mouse Inhalation Model: Proof of Concept

  2021influential citation
• Characterization of Schu S4 aro mutants as live attenuated tularemia vaccine candidates

  2020cites this paper
• Tularemia: Epidemiology, Ecology, Genomics, Immunity and Pathogenesis

  2020cites this paper
• An O -

  2019cites this paper
• A Francisella novicida Mutant, Lacking the Soluble Lytic Transglycosylase Slt, Exhibits Defects in Both Growth and Virulence

  2019cites this paper
• Global Analysis of Genes Essential for Francisella tularensis Schu S4 Growth In Vitro and for Fitness during Competitive Infection of Fischer 344 Rats

  2019cites this paper
• Biological amplification of low frequency mutations unravels laboratory culture history of the bio-threat agent Francisella tularensis.

  2019cites this paper
• Development of DNA vaccines encoding ribosomal proteins (RplL and RpsA) against Nocardia seriolae infection in fish.

  2019cites this paper
• Protective effects of the Francisella tularensis ΔpdpC mutant against its virulent parental strain SCHU P9 in Cynomolgus macaques

  2019cites this paper
• Live Attenuated Tularemia Vaccines for Protection Against Respiratory Challenge With Virulent F. tularensis subsp. tularensis

  2018cites this paper
• Deletion of the Major Facilitator Superfamily Transporter fptB Alters Host Cell Interactions and Attenuates Virulence of Type A Francisella tularensis

  2018cites this paper
• Adaptive Immunity to Francisella tularensis and Considerations for Vaccine Development

  2018cites this paper
• A panel of correlates predicts vaccine-induced protection of rats against respiratory challenge with virulent Francisella tularensis

  2018cites this paper
• Differential In Vitro Cultivation of Francisella tularensis Influences Live Vaccine Protective Efficacy by Altering the Immune Response

  2018cites this paper
• An O-Antigen Glycoconjugate Vaccine Produced Using Protein Glycan Coupling Technology Is Protective in an Inhalational Rat Model of Tularemia

  2018cites this paper
• Evaluation of Francisella tularensis ΔpdpC as a candidate live attenuated vaccine against respiratory challenge by a virulent SCHU P9 strain of Francisella tularensis in a C57BL/6J mouse model

  2018cites this paper
• Deletion of the MFS transporter fptB alters host cell interactions and attenuates the virulence of Type A Francisella tularensis

  2018cites this paper
• Differential Growth of Francisella tularensis, Which Alters Expression of Virulence Factors, Dominant Antigens, and Surface-Carbohydrate Synthases, Governs the Apparent Virulence of Ft SchuS4 to Immunized Animals

  2017cites this paper
• Evaluation of Francisella tularensis Δ pdpC as a candidate live attenuated vaccine against respiratory challenge of Tularemia in C 57 BL / 6 J mouse model Running title : Evaluation of Δ pdpC in mice

  2017cites this paper
• Progress, challenges, and opportunities in Francisella vaccine development

  2016cites this paper
• Identification of two novel in vivo-upregulated Francisella tularensis proteins involved in metal acquisition and virulence

  2016cites this paper
• GM-CSF has disparate roles during intranasal and intradermal Francisella tularensis infection.

  2016cites this paper
• Tularemia vaccine development: paralysis or progress?

  2016cites this paper
• Tularemia vaccines

  2016cites this paper
• 229 – Francisella tularensis (Tularemia)

  2015cites this paper
• High-Quality Draft Genome Sequence of Francisella tularensis subsp. holarctica Strain OR96-0246

  2015cites this paper
• Francisella tularensis Vaccines Elicit Concurrent Protective T- and B-Cell Immune Responses in BALB/cByJ Mice

  2015influential citation
• Next Generation Vaccine Biomarkers workshop October 30–31, 2014 – Ottawa, Canada

  2015cites this paper
• Identification of Mechanisms for Attenuation of the FSC043 Mutant of Francisella tularensis SCHU S4

  2014cites this paper
• Successful Protection against Tularemia in C57BL/6 Mice Is Correlated with Expansion of Francisella tularensis-Specific Effector T Cells

  2014influential citation
• Identification and characterization of capsule and/or O-antigen mutants of Francisella tularensis Schu S4

  2014cites this paper
• Francisella tularensis LVS Surface and Membrane Proteins as Targets of Effective Post-Exposure Immunization for Tularemia

  2014cites this paper
• TLR2 Signaling is Required for the Innate, but Not Adaptive Response to LVS clpB

  2014cites this paper
• Utforsking av faktorer som kan påvirke vekst hos Francisella noatunensis subsp. i laboratoriet og kloning av clpB for funksjonsanalyser av proteinet ClpB hos F. noatunensis subsp noatunensis.

  2013cites this paper
• Correlates of protection following vaccination of mice with gene deletion mutants of Francisella tularensis subspecies tularensis strain, SCHU S4 that elicit varying degrees of immunity to systemic and respiratory challenge with wild-type bacteria.

  2013cites this paper
• Live attenuated tularemia vaccines: recent developments and future goals.

  2013cites this paper
• to an altered yet protective immune response

  2013cites this paper
• A ΔclpB Mutant of Francisella tularensis Subspecies holarctica Strain, FSC200, Is a More Effective Live Vaccine than F. tularensis LVS in a Mouse Respiratory Challenge Model of Tularemia

  2013cites this paper
• Novel Catanionic Surfactant Vesicle Vaccines Protect against Francisella tularensis LVS and Confer Significant Partial Protection against F. tularensis Schu S4 Strain

  2013cites this paper
• Infection with Francisella tularensis LVS clpB Leads to an Altered yet Protective Immune Response

  2013cites this paper
• Animal Models for Francisella tularensis and Burkholderia Species

  2013cites this paper
• Immune evasion strategies utilized by Francisella tularensis

  2013influential citation
• Proteomic Analysis and Immunogenicity of Mannheimia haemolytica Vesicles

  2012cites this paper
• Identification of a Live Attenuated Vaccine Candidate for Tularemia Prophylaxis

  2012cites this paper
• Enhancement of Antigen-Specific Immunoglobulin G Responses by Anti-CD48

  2012cites this paper